# Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis

> **NCT00004736** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 44 (—)

## Conditions studied

- HIV Infections
- Tuberculosis

## Interventions

- **DRUG:** Nelfinavir mesylate
- **DRUG:** Ethambutol hydrochloride
- **DRUG:** Isoniazid
- **DRUG:** Pyrazinamide
- **DRUG:** Lamivudine
- **DRUG:** Rifabutin
- **DRUG:** Stavudine
- **DRUG:** Zidovudine

## Key facts

- **NCT ID:** NCT00004736
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 44 (—)
- **Last updated:** 2008-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004736, "Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00004736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*